
VRAX Market Capitalization Overview
Market Cap: $3.84M as of Jun 13, 2025
$3.84M
Past Month-$770.70K (16.75%)
As of Jun 13, 2025, VRAX has a market capitalization of $3.84M. Over the past 30 days, its market cap has increased by 0%, while in the last 12 months, it has decreased by -60.78%.
Market capitalization represents the total value of Virax Biolabs Group Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
VRAX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of VRAX helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Virax Biolabs Group Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
VRAX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of VRAX helps investors assess the company's size and compare it with competitors for better investment decisions.
VRAX Market Cap & Key Trends
See Virax Biolabs Group Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in VRAX
Order type
Buy in
Order amount
Est. shares
0 shares
VRAX Market Cap History
Date | Market Cap | Change |
---|---|---|
Jun 2, 2025 | $4.26M | 0.00% |
May 1, 2025 | $4.26M | -10.74% |
Apr 1, 2025 | $4.77M | -30.95% |
Mar 3, 2025 | $6.91M | -4.79% |
Feb 3, 2025 | $7.26M | -24.43% |
Jan 2, 2025 | $9.60M | +13.33% |
VRAX End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $3.84M | -60.78% |
2024 | $9.77M | -56.96% |
2023 | $22.70M | -72.66% |
2022 | $83.04M | — |
FAQs About Virax Biolabs Group Ltd (VRAX) Market Cap
As of Jun 13, 2025, the market capitalization of VRAX is $3.84M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Virax Biolabs Group Ltd’s market capitalization has decreased by -16.75%, changing from $4.61M to $3.84M as of Jun 13, 2025.
In the last 3 months, Virax Biolabs Group Ltd’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, Virax Biolabs Group Ltd’s market capitalization decreased from $22.70M in January to $9.77M in December, reflecting a -56.96% change.
In the past five years, VRAX has had a compound annual growth rate (CAGR) of -51.00% in market capitalization. This means its market cap has shrunk at an average rate of -51.00% per year.